Fluzone High-Dose Sanofi-Aventis Australia Pty Ltd
Product name
Fluzone High-Dose
Sponsor
Accepted date
Jun-2026
Active ingredients
Influenza virus haemagglutinin
Summary of proposed indication
FLUZONE High-Dose (influenza virus haemagglutinin) is a vaccine proposed to immunise people aged 50 years and older against influenza.
Application type
C (new indication)
Publication date
Jun-2026